Jpmorgan Chase & CO Iovance Biotherapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,892,932 shares of IOVA stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,892,932

Previous 3,438,232 44.94%

Holding current value

$14 Million

Previous $27.6 Million 35.54%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$7.28 - $11.9 $11.2 Million - $18.4 Million	-1,545,300 Reduced 44.94%	1,892,932 $17.8 Million
Q2 2024 Aug 12, 2024	SELL	$7.78 - $14.19 $7.37 Million - $13.4 Million	-947,462 Reduced 21.6%	3,438,232 $27.6 Million
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $11.7 Million - $27 Million	1,546,027 Added 54.44%	4,385,694 $65 Million
Q4 2023 Feb 12, 2024	BUY	$3.3 - $8.89 $307,926 - $829,534	93,311 Added 3.4%	2,839,667 $23.1 Million
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $493,146 - $976,296	111,069 Added 4.21%	2,746,356 $12.5 Million
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $3.03 Million - $5.13 Million	565,916 Added 27.35%	2,635,287 $18.6 Million
Q1 2023 May 18, 2023	BUY	$5.53 - $8.22 $1.01 Million - $1.5 Million	182,760 Added 9.69%	2,069,371 $12.6 Million
Q1 2023 May 11, 2023	SELL	$5.53 - $8.22 $2.49 Million - $3.69 Million	-449,509 Reduced 19.24%	1,886,611 $11.5 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $1.25 Million - $2.23 Million	222,842 Added 10.54%	2,336,120 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $682,433 - $938,793	71,609 Added 3.51%	2,113,278 $20.2 Million
Q2 2022 Aug 11, 2022	BUY	$6.38 - $18.33 $1.2 Million - $3.44 Million	187,936 Added 10.14%	2,041,669 $22.5 Million
Q1 2022 May 11, 2022	SELL	$12.38 - $19.1 $2.03 Million - $3.13 Million	-163,698 Reduced 8.11%	1,853,733 $30.9 Million
Q4 2021 Feb 10, 2022	BUY	$16.55 - $27.63 $6.27 Million - $10.5 Million	378,695 Added 23.11%	2,017,431 $38.5 Million
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $33.3 Million - $43.6 Million	1,638,736 New	1,638,736 $40.4 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Iovance Biotherapeutics, Inc. Transaction History